Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Elevance Health Inc.

Elevance Health Inc. (ELV) Stock Overview

Explore Elevance Health Inc.’s financial performance, market position, analyst ratings, and future outlook.

ELV●NYSE
HealthcareMedical - Healthcare Plans
$428.09
$2.82(0.66%)
U.S. Market opens in 2h 32m

Elevance Health Inc. (ELV)

Meyka AI Score

Z

Key Financials

Market Cap92.8B
P/E Ratio18.98
EPS (TTM)$29.39
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$340.46
3 Months$368.45
1 Year Target$341.63

ELV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Elevance Health Inc. (NYSE: ELV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Elevance Health Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ELV on the NYSE shows an RSI of 65.41, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $341.63 for the NYSE listing.

Key metrics behind Elevance Health Inc.'s NYSE-traded stock include a P/E ratio of 18.98 and a market capitalization of 92.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ELV on the NYSE.

Price Performance (NYSE: ELV)

1-Day Change
0.67%
5-Day Change
6.51%
1-Month Change
0.91%
3-Month Change
0.31%
6-Month Change
36.62%
Year-to-Date (YTD) Change
22.12%
1-Year Change
22.15%
3-Year Change
-7.46%
5-Year Change
9.57%
All-Time (Max) Change
1993.40%

Contact Information

https://www.elevancehealth.com
800 331 1476
220 Virginia Avenue, Indianapolis, IN, 46204

Company Facts

966,150 Employees
IPO DateOct 30, 2001
CountryUS
Actively Trading

Frequently Asked Questions